(a) Gene-editing strategy using a single sgRNA targeting the first exon of zebrafish ntn1a. CRISPR/Cas9 was used to generate heterozygous (ntn1+/-; G0) founders. These were crossed to generate homozygous G1 embryos (ntn1-/-). (b) Panels showing the coloboma microphthalmia and coloboma (arrow) phenotypes in gene-edited ntn1-/- embryos compared to wild-type. (c) Sanger sequencing confirmed the homozygous gene-edited ntn1a allele in 100% of phenotypic G1 embryos. (d) In silico translation of encoded mutant allele aligned to wild-type (first 153 amino acids shown of 603 aa ntn1a protein are shown). The gene edited mutation encodes a frame-shift in the first exon resulting in a truncated ntn1a of 105 amino acids (p.Cys90Ala.fs15). (e) Morpholino experiments produced bilateral coloboma in 100% of embryos injected with ntn1a translation-blocking MO, with no ocular phenotypes observed in control MO injected embryos. The optic fissures are indicated by arrows. (f) Tables with penetrance of colobomas in gene-edited embryos and MO embryos compared to controls.
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Elife
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.